SEC Comment Letter 0000000000-26-007928 to Opus Genetics, Inc. (IRD) (CIK 0001228627) (IRD)
Opus Genetics, Inc. (IRD) (CIK 0001228627)
Date: Aug. 12, 2026 · CIK: 0001228627 · Accession: 0000000000-26-007928
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-298100
Letter
Re: Opus Genetics, Inc. Registration Statement on Form S-3 Filed August 7, 2026 File No. 333-298100 Dear George Magrath: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions.
August 12, 2026
George Magrath Chief Executive Officer Opus Genetics, Inc. 8 Davis Drive, Suite 220 Durham, NC 27713
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Istvan A. Hajdu, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 12, 2026 George Magrath Chief Executive Officer Opus Genetics, Inc. 8 Davis Drive, Suite 220 Durham, NC 27713 Re: Opus Genetics, Inc. Registration Statement on Form S-3 Filed August 7, 2026 File No. 333-298100 Dear George Magrath: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Istvan A. Hajdu, Esq. </TEXT> </DOCUMENT>